Masters Tickets to Benefit ALS Research Offered by Watson, Edwards and Julian
ALS Therapy Development Foundation's 'Driving 4 Life' Program to Raffle Off
the Ultimate Golf Experience
CAMBRIDGE, Mass., April 3 /PRNewswire/ -- Driving 4 Life, the ALS fundraising campaign supported by World Hall of Fame Golfer Tom Watson, his caddy Bruce Edwards and former PGA TOUR Pro Jeff Julian, is providing a chance for golf fans nationwide to receive the most sought after tickets in sports -- the 2004 Masters Tournament at Augusta National. Driving 4 Life and the ALS Therapy Development Foundation are holding a raffle at www.driving4life.org to award the following to the holder of the winning ticket chosen on Monday April 5th at 5:00pm EST. * Two Masters Tournament badges for Sunday April 11th * Accommodations in private residence in Augusta on Saturday April 10th * Complimentary local transportation in Augusta for the weekend * Each raffle ticket is $50. The Masters Tournament is significant for both Bruce Edwards and Jeff Julian, who have both been diagnosed with ALS. Last year, Jeff Julian received the Golf Writers Association of America's Ben Hogan Award, given annually to an individual who has continued to be active in golf despite a physical handicap or serious illness. This year, Bruce Edwards will be receiving the Ben Hogan Award. Bruce Edwards's life is chronicled in a new book by best-selling sportswriter John Feinstein. CADDY FOR LIFE: The Bruce Edwards Story will be available in bookstores everywhere on Tuesday, April 6. There is currently no cure for ALS, in which the body's nervous system gradually degenerates, robbing its victims of the ability to walk, speak and, eventually, swallow or breathe. Most ALS victims live two to five years after diagnosis. Proceeds from the raffle will directly benefit the ALS Therapy Development Foundation (ALSTDF), the leading drug discovery center for today's ALS patients. James Heywood, whose brother, Stephen, was diagnosed with ALS, founded ALSTDF in 1999. The nonprofit biotechnology company researches and screens drugs, and develops pre-clinical and clinical trials to translate these drugs into potential treatments for ALS victims. For more information on the ALS Therapy Development Foundation, please visit www.als.net. Press Contact: Tyson Goodridge firstname.lastname@example.org
SOURCE ALS Therapy Development Foundation
More by this Source
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.